Elite Pharmaceuticals Inc (ELTP)

[Bngo]

My most recent text to many of my family members, friends, and peers was last Sunday.
Hopefully the information is correct based on what I have seen on this board.
Feel free to add, modify, and pass this information on to your family, friends, and peers also.

Anyway, so many of them have joined us ELTP long investors and invested in ELTP, and all of them are happy and in the positive.


1 ELTP press release was announced several days ago,
and its price per share shot up from $0.20 to $0.28
…a 40% increase

https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=137279&BzID=2258&g=939&Nav=0&LangID=1&s=0

At least 5 more press releases are about to be announced in the very near future.

ELTP approved drugs with pending launches:

1. Methotrexate
$64 million market
Just launched on 8/27/24

2. Codeine with acetaminophen
$45 million market
Will launch 6-8 weeks after the methotrexate launch

3. Generic Percocet
oxycodone with acetaminophen
$500 million market
Will launch 6-8 weeks after the codeine with acetaminophen launch

4. Generic Norco
hydrocodone with acetaminophen
$477 million market
Will launch 6-8 weeks after the oxycodone with acetaminophen launch

5. Dolophine/Methadone
$30 million market
Will launch 6-8 weeks after the hydrocodone with acetaminophen launch

Pending approval:
Generic Vyvanse
$5.1 billion market
This is the monster news that everyone is waiting for.
Hopefully the approvable positive press release will come out by November 2024.

Pending approval:
Generic OxyContin
$720 million market

Pending approval:
Generic Vigabatrin
$233 Million market

Pending submittal:
Generic Concerta
$1.2 billion market

Pending submittal:
Generic Requip XL or
Generic Mirapex ER
$12 Million market

64 + 45 + 500 + 477 + 30 + 720 + 233 + 12 = $2.081 Billion

2.081 + 5.1 + 1.2 = $8.381 Billion